{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:46:22Z","timestamp":1791549982039,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T00:00:00Z","timestamp":1635033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.eururo.2021.10.032","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T05:52:42Z","timestamp":1637128362000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance\u2013Ultrasound Fusion Guided Biopsy Using Local Anesthesia"],"prefix":"10.1016","volume":"81","author":[{"given":"Jos","family":"Immerzeel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Isra\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce","family":"Bomers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo G.","family":"Schoots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"van Basten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl-Heinz","family":"Kurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"de Reijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Sedelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans","family":"Debruyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Barentsz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2021.10.032_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2021.10.032_b0010","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0015","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JU.0000000000000617","article-title":"Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer","volume":"203","author":"Bjurlin","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0025","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouviere","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2021.10.032_b0030","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2021.10.032_b0035","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1001\/jamaoncol.2020.7589","article-title":"Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial","volume":"7","author":"Klotz","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2021.10.032_b0040","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1148\/radiol.2017161684","article-title":"The current state of MR imaging-targeted biopsy techniques for detection of prostate cancer","volume":"285","author":"Verma","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2021.10.032_b0045","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.eururo.2019.10.009","article-title":"Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 3: targeted biopsy","volume":"77","author":"Venderink","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0050","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/JU.0000000000001399","article-title":"Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"205","author":"Pradere","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.eururo.2021.10.032_b0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.eururo.2019.06.011","article-title":"Time to adapt our practice? The European Commission has restricted the use of fluoroquinolones since March 2019","volume":"76","author":"Bonkat","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0065","unstructured":"FDA. Drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm511530.htm."},{"key":"10.1016\/j.eururo.2021.10.032_b0070","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","article-title":"Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis?","volume":"62","author":"Carignan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0075","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0080","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/JU.0000000000000156","article-title":"Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. Prostate cancer detection rate, complications and patient tolerability","volume":"201","author":"Stefanova","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/pcan.2017.13","article-title":"Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach","volume":"20","author":"Bass","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.eururo.2021.10.032_b0090","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.urology.2009.09.083","article-title":"Periprostatic local anesthesia with pudendal block for transperineal ultrasound-guided prostate biopsy: a randomized trial","volume":"75","author":"Iremashvili","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2021.10.032_b0095","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.eururo.2019.09.021","article-title":"Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 1: acquisition","volume":"77","author":"Engels","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.eururo.2019.10.024","article-title":"Multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer: what urologists need to know. Part 2: interpretation","volume":"77","author":"Israel","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0105","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.eururo.2015.08.052","article-title":"PI-RADS Prostate Imaging - Reporting and Data System: 2015, version 2","volume":"69","author":"Weinreb","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0110","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.euf.2017.02.014","article-title":"Validation of the Clavien-Dindo grading system in urology by the European Association of Urology Guidelines Ad Hoc Panel","volume":"4","author":"Mitropoulos","year":"2018","journal-title":"Eur Urol Focus."},{"key":"10.1016\/j.eururo.2021.10.032_b0115","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eururo.2021.10.032_b0120","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.eururo.2013.03.030","article-title":"Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an international working group","volume":"64","author":"Moore","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0125","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"75","author":"Assel","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0130","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/end.2020.1093","article-title":"\u201cFree-hand\u201c transperineal prostate biopsy under local anesthesia: review of the literature","volume":"35","author":"Szabo","year":"2021","journal-title":"J Endourol"},{"key":"10.1016\/j.eururo.2021.10.032_b0135","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.urology.2019.11.078","article-title":"Transperineal free-hand mpMRI fusion-targeted biopsies under local anesthesia: technique and feasibility from a single-center prospective study","volume":"140","author":"Marra","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2021.10.032_b0140","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/bju.14620","article-title":"Initial outcomes of local anaesthetic freehand transperineal prostate biopsies in the outpatient setting","volume":"125","author":"Kum","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2021.10.032_b0145","doi-asserted-by":"crossref","first-page":"368","DOI":"10.21037\/tau.2017.03.58","article-title":"Transperineal vs. transrectal biopsy in MRI targeting","volume":"6","author":"Grummet","year":"2017","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0150","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00345-016-1985-1","article-title":"Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cephazolin prophylaxis","volume":"35","author":"Pepdjonovic","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0155","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.urology.2013.02.019","article-title":"Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores","volume":"81","author":"Pepe","year":"2013","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2021.10.032_b0160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.15062","article-title":"The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008\u20132019","volume":"126","author":"Tamhankar","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2021.10.032_b0165","article-title":"Magnetic resonance imaging\/ultrasound fusion-guided transperineal versus magnetic resonance imaging\/ultrasound fusion-guided transrectal prostate biopsy\u2014a systematic review","author":"Rai","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.eururo.2021.10.032_b0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2020.10.019","article-title":"European Association of Urology position paper on the prevention of infectious complications following prostate biopsy","volume":"79","author":"Pilatz","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0175","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study","volume":"389","author":"Ahmed","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2021.10.032_b0180","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.eururo.2016.02.064","article-title":"Magnetic resonance and ultrasound image fusion supported transperineal prostate biopsy using the Ginsburg protocol: technique, learning points, and biopsy results","volume":"70","author":"Hansen","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0185","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2021.10.032_b0190","article-title":"Detection of significant prostate cancer using target saturation in transperineal magnetic resonance imaging\/transrectal ultrasonography-fusion biopsy","author":"Tschirdewahn","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2021.10.032_b0195","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.eururo.2021.01.039","article-title":"Perilesional biopsies increase detection of significant prostate cancer in men with PI-RADS 4\/5 lesions: validation of the PI-RADS Steering Committee recommendation","volume":"80","author":"Lahoud","year":"2021","journal-title":"Eur Urol."},{"key":"10.1016\/j.eururo.2021.10.032_b0200","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00345-018-02622-5","article-title":"Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach?","volume":"37","author":"Marra","year":"2019","journal-title":"World J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283821021357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283821021357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:10:20Z","timestamp":1759583420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283821021357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0302283821021357"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2021.10.032","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance\u2013Ultrasound Fusion Guided Biopsy Using Local Anesthesia","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2021.10.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}